Sibutramine shown the door in the US, Australia, Canada and NZ

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1323, 2010-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Australia's TGA and NZ's Medsafe to merge

By  

Reactions Weekly, Vol. 1, Iss. 1357, 2011-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

The expected start time for a joint regulatory scheme for therapeutic products in Australia and New Zealand (NZ) is now the second half of 2007

By  

Reactions Weekly, Vol. 1, Iss. 1102, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Hydroxycut products withdrawn in US and Canada

By  

Reactions Weekly, Vol. 1, Iss. 1251, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Is it bye-bye Bextra in the US, EU and Canada?

By  

Reactions Weekly, Vol. 1, Iss. 1047, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Use of generics encouraged in the US and Quebec, Canada

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 364, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite